We help build successful companies that are tackling autism and a range of neurodevelopmental conditions.


We are investors, entrepreneurs, human resource professionals, scientists, researchers, and physicians committed to identifying unmet needs across the continuum of autism and deploying venture capital to fuel solutions to those needs



AIF is led by a team with robust experience across the financial, venture capital, and life sciences sectors.



An innovative and patient-oriented scientist, Ashok Srinivasan has an extensive history of leadership in clinical and basic science.

As the Translational Research Scientist for NSABP Foundation/NRG Pittsburgh, Ashok has dedicated the past seven years to translating scientific advances to clinical trials, supporting new technology and therapeutic advancements for breast and colorectal cancer. In this role, Ashok has consulted as a molecular genetics / genomics expert in developing scientific rationales for 10+ clinical trials and educated clinical trialists on emerging trends and best practices in oncology research.



Michelle He, Associate, executes due diligence on potential opportunities and supports AIF’s existing portfolio companies, leveraging her valuation expertise acquired as an Investment Banking Analyst in the Financial Sponsors Group at Morgan Stanley.

Michelle holds a B.S. double major in Business Administration and Statistics/Analytics, with a minor in
Neuroscience, from the University of North Carolina at Chapel Hill, where she was a GLOBE Scholar. She resides in New York City.



Kelly Patterson, Head of Investor Relations & Fund Administration, is responsible for managing all relationship activity, in addition to fund administration, for AIF. Kelly previously worked for 18+ years in the professional sports and entertainment managing key corporate and consumer products partners.​

Kelly holds a B.A. in fine arts from Colby College where she played ice hockey. She currently lives in Far Hills, NJ with her husband, newborn son and two dogs.



Dan Tarman has 30+- years of professional and executive experience. Starting his career as a litigation attorney and continuing in the corporate world, has worked at a number of leading companies in senior marketing, brand strategy and corporate communications roles.



The Investment Advisory Team provides transaction advisory analysis, networking opportunities, and guidance on growth strategy for AIF’s portfolio companies. Each advisor has been greatly affected by autism.

Johan Andresen

Owner & Chair, Ferd

Cuong Do

President, Samsung Corporate Strategy Group

Jennifer Frist

Philanthropist, Frist Center For Autism And Innovation At Vanderbilt University


Raymond “Rip” Gellein, Jr.

Vice Chairman, Mind & Life Institute

Arun Gupta

Founder & CEO, Quartet, Accretive, The World Bank, McKinsey

Sarah Hassan

Healthcare Investor & Entrepreneur


Elizabeth Horn

Founder & CEO 2M, COMPASS
AIF Founding LP

Brian Jacobs

Venture Capitalist Emergence, Moai Capital

Dara Khosrowshahi

CEO, Uber


Amanda Lukof

Special Needs Advocate


Bob Nelsen

Co-Founder & Managing Director, ARCH Venture Partners


Sean O'Sullivan

SOSV (IndieBio, Hax)


Mike Smart

Partner, Dominus Capital

"Venture capital is the accelerant that brings breakthrough technologies into markets. With millions of kids and adults suffering from severe medical and physiological challenges due to autism, now is the time for the Autism Impact Fund. "

- Sean O’Sullivan, AIF Advisor & Founding LP



The Scientific Advisory Board encompasses individuals with deep expertise in autism, academia, and industry. Each advisor provides scientific review and strategic thinking for the AIF.

David Amaral, PhD

Director Of The Autism Center Of Excellence At UC Davis

Sir Simon Baron-Cohen, PhD

Director Of The Autism Research Centre, University Of Cambridge

Larry Derose

Founder And CEO, AdvaStim, Inc.

Richard Frye, MD, PhD

Director Of Autism Research, Arkansas Children's Hospital

Tom Insel, MD

Co-Founder, Mindstrong, NIH

Ian Marks

Global VP Life Sciences, Salesforce, GSK, Novartis, Roche

Krishnan Nandabalan, PhD

CEO, Founder, & President, InveniAI

Alison Singer

Co-Founder & President, Autism Science Foundation

Mike Snyder, PhD

Chair Of Genomics, Stanford Medical School

Pramila Srinivasan, PhD

CEO Of ChARM Health